Integrated Diagnostics Holdings PLC
LSE:IDHC
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.2845
0.535
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one IDHC stock under the Base Case scenario is 0.5669 USD. Compared to the current market price of 0.3955 USD, Integrated Diagnostics Holdings PLC is Undervalued by 30%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Integrated Diagnostics Holdings PLC
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for IDHC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Integrated Diagnostics Holdings PLC
Balance Sheet Decomposition
Integrated Diagnostics Holdings PLC
Current Assets | 2.7B |
Cash & Short-Term Investments | 1.3B |
Receivables | 886.1m |
Other Current Assets | 536.4m |
Non-Current Assets | 4.1B |
PP&E | 2.3B |
Intangibles | 1.8B |
Current Liabilities | 1.7B |
Accounts Payable | 283.5m |
Accrued Liabilities | 281m |
Other Current Liabilities | 1.1B |
Non-Current Liabilities | 2.3B |
Long-Term Debt | 1B |
Other Non-Current Liabilities | 1.3B |
Earnings Waterfall
Integrated Diagnostics Holdings PLC
Revenue
|
4.7B
EGP
|
Cost of Revenue
|
-3B
EGP
|
Gross Profit
|
1.8B
EGP
|
Operating Expenses
|
-883.9m
EGP
|
Operating Income
|
907.4m
EGP
|
Other Expenses
|
-90.1m
EGP
|
Net Income
|
817.3m
EGP
|
Free Cash Flow Analysis
Integrated Diagnostics Holdings PLC
EGP | |
Free Cash Flow | EGP |
IDHC Profitability Score
Profitability Due Diligence
Integrated Diagnostics Holdings PLC's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Score
Integrated Diagnostics Holdings PLC's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
IDHC Solvency Score
Solvency Due Diligence
Integrated Diagnostics Holdings PLC's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Score
Integrated Diagnostics Holdings PLC's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IDHC Price Targets Summary
Integrated Diagnostics Holdings PLC
According to Wall Street analysts, the average 1-year price target for IDHC is 0.545 USD with a low forecast of 0.4545 USD and a high forecast of 0.714 USD.
Dividends
Current shareholder yield for IDHC is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Integrated Diagnostics Holdings Plc engages in the provision of diagnostics services including pathology and molecular diagnostics, genetics testing and basic radiology to patients and other laboratories. The firm operates in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The company is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology and radiology. Its brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan (both in Sudan), and Echo-Lab (Nigeria). The company operates in approximately 507 branches. IDH offers 2,000 diagnostic pathology tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy, and substance abuse. Through Al Borg Scan, it offers a range of radiology services, including but not limited to magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, x-ray, mammograms, cath lab facilities, and positron emission tomography-computed tomography (PET-CT).
Contact
IPO
Employees
Officers
The intrinsic value of one IDHC stock under the Base Case scenario is 0.5669 USD.
Compared to the current market price of 0.3955 USD, Integrated Diagnostics Holdings PLC is Undervalued by 30%.